Gizmodo

It’s not only food CEOs who need to worry about their bottom lines thanks to in-demand weight loss drugs like Ozempic. Big Tobacco and Alcohol have reason to fret, too.

Read more...

Morgan Stanley, anti obesity medication, tirzepatide, health medical pharma, glp 1 receptor agonist, semaglutide, Alcohol, glucagon like peptide 1, peptide therapeutics, peptide hormones, draftfood noise, glp 1, anti diabetic drugs, glp1 poly agonist peptides
Source
Weight Loss Drug Users Are Giving Up Their Vices